Lack of muco-cutaneous signs of toxic shock syndrome when t cells are absent: S. aureus shock in immunodeficient adults with multiple myeloma

N. S. Kamel, Michael C Banks, A. Dosik, D. Ursea, A. A. Yarilina, D. N. Posnett

Research output: Contribution to journalArticle

Abstract

Staphylococcal toxic shock syndrome (TSS) is an acute life threatening disease. The diagnosis can be made clinically based on diagnostic criteria. The clinical manifestations are caused in large part by the release of high levels of T-cell-derived cytokines as a result of potent toxins, also called superantigens (SAg), produced by Staphylococcus aureus, but it is not clear which clinical symptoms/signs are strictly T-cell dependent. Here, we report on three adults with multiple myeloma (MM) presenting with S. aureus sepsis/shock, and two patients with typical TSS. The MM patients had compromised humoral immunity because of depression of normal immunoglobulin (Ig) levels at the expense of the M protein. In addition, their T cells were absent due to high dose chemotherapy initiated for bone marrow transplantation. The MM cases lacked mucosal hyperemia, erythroderma and desquamation, but were otherwise indistinguishable from the TSS cases. All patients grew S. aureus and in each case, SAg genes were detected by PCR. In several cases, the plasma contained biological SAg activity resulting in Vβ specific proliferation of indicator T cellsin vitro. The same specific activity was observed with the supernatant fluids of S. aureus broth cultures from the respective bacterial isolates. This confirms the presence of bio-active toxins in the plasma but did not lead to full blown TSS when T cells were lacking. Thus, S. aureus sepsis/shock can be clinically distinguished from typical TSS, and we suggest that muco-cutaneous manifestations of TSS are the most telling signs of massive T-cell-dependent cytokine release.

Original languageEnglish (US)
Pages (from-to)131-139
Number of pages9
JournalClinical and Experimental Immunology
Volume128
Issue number1
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Septic Shock
Multiple Myeloma
Shock
Staphylococcus aureus
Superantigens
Skin
T-Lymphocytes
Sepsis
Cytokines
Exfoliative Dermatitis
Skin Manifestations
Hyperemia
Humoral Immunity
Bone Marrow Transplantation
Signs and Symptoms
Immunoglobulins
Drug Therapy
Polymerase Chain Reaction
Genes
Proteins

Keywords

  • Immunodeficiency
  • Multiple myeloma
  • Staphylococcus aureus
  • Superantigen
  • Toxic shock syndrome

ASJC Scopus subject areas

  • Immunology

Cite this

Lack of muco-cutaneous signs of toxic shock syndrome when t cells are absent : S. aureus shock in immunodeficient adults with multiple myeloma. / Kamel, N. S.; Banks, Michael C; Dosik, A.; Ursea, D.; Yarilina, A. A.; Posnett, D. N.

In: Clinical and Experimental Immunology, Vol. 128, No. 1, 2002, p. 131-139.

Research output: Contribution to journalArticle

@article{39f266abe111498a98c4451a22002a0d,
title = "Lack of muco-cutaneous signs of toxic shock syndrome when t cells are absent: S. aureus shock in immunodeficient adults with multiple myeloma",
abstract = "Staphylococcal toxic shock syndrome (TSS) is an acute life threatening disease. The diagnosis can be made clinically based on diagnostic criteria. The clinical manifestations are caused in large part by the release of high levels of T-cell-derived cytokines as a result of potent toxins, also called superantigens (SAg), produced by Staphylococcus aureus, but it is not clear which clinical symptoms/signs are strictly T-cell dependent. Here, we report on three adults with multiple myeloma (MM) presenting with S. aureus sepsis/shock, and two patients with typical TSS. The MM patients had compromised humoral immunity because of depression of normal immunoglobulin (Ig) levels at the expense of the M protein. In addition, their T cells were absent due to high dose chemotherapy initiated for bone marrow transplantation. The MM cases lacked mucosal hyperemia, erythroderma and desquamation, but were otherwise indistinguishable from the TSS cases. All patients grew S. aureus and in each case, SAg genes were detected by PCR. In several cases, the plasma contained biological SAg activity resulting in Vβ specific proliferation of indicator T cellsin vitro. The same specific activity was observed with the supernatant fluids of S. aureus broth cultures from the respective bacterial isolates. This confirms the presence of bio-active toxins in the plasma but did not lead to full blown TSS when T cells were lacking. Thus, S. aureus sepsis/shock can be clinically distinguished from typical TSS, and we suggest that muco-cutaneous manifestations of TSS are the most telling signs of massive T-cell-dependent cytokine release.",
keywords = "Immunodeficiency, Multiple myeloma, Staphylococcus aureus, Superantigen, Toxic shock syndrome",
author = "Kamel, {N. S.} and Banks, {Michael C} and A. Dosik and D. Ursea and Yarilina, {A. A.} and Posnett, {D. N.}",
year = "2002",
doi = "10.1046/j.1365-2249.2002.01805.x",
language = "English (US)",
volume = "128",
pages = "131--139",
journal = "Clinical and Experimental Immunology",
issn = "0009-9104",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Lack of muco-cutaneous signs of toxic shock syndrome when t cells are absent

T2 - S. aureus shock in immunodeficient adults with multiple myeloma

AU - Kamel, N. S.

AU - Banks, Michael C

AU - Dosik, A.

AU - Ursea, D.

AU - Yarilina, A. A.

AU - Posnett, D. N.

PY - 2002

Y1 - 2002

N2 - Staphylococcal toxic shock syndrome (TSS) is an acute life threatening disease. The diagnosis can be made clinically based on diagnostic criteria. The clinical manifestations are caused in large part by the release of high levels of T-cell-derived cytokines as a result of potent toxins, also called superantigens (SAg), produced by Staphylococcus aureus, but it is not clear which clinical symptoms/signs are strictly T-cell dependent. Here, we report on three adults with multiple myeloma (MM) presenting with S. aureus sepsis/shock, and two patients with typical TSS. The MM patients had compromised humoral immunity because of depression of normal immunoglobulin (Ig) levels at the expense of the M protein. In addition, their T cells were absent due to high dose chemotherapy initiated for bone marrow transplantation. The MM cases lacked mucosal hyperemia, erythroderma and desquamation, but were otherwise indistinguishable from the TSS cases. All patients grew S. aureus and in each case, SAg genes were detected by PCR. In several cases, the plasma contained biological SAg activity resulting in Vβ specific proliferation of indicator T cellsin vitro. The same specific activity was observed with the supernatant fluids of S. aureus broth cultures from the respective bacterial isolates. This confirms the presence of bio-active toxins in the plasma but did not lead to full blown TSS when T cells were lacking. Thus, S. aureus sepsis/shock can be clinically distinguished from typical TSS, and we suggest that muco-cutaneous manifestations of TSS are the most telling signs of massive T-cell-dependent cytokine release.

AB - Staphylococcal toxic shock syndrome (TSS) is an acute life threatening disease. The diagnosis can be made clinically based on diagnostic criteria. The clinical manifestations are caused in large part by the release of high levels of T-cell-derived cytokines as a result of potent toxins, also called superantigens (SAg), produced by Staphylococcus aureus, but it is not clear which clinical symptoms/signs are strictly T-cell dependent. Here, we report on three adults with multiple myeloma (MM) presenting with S. aureus sepsis/shock, and two patients with typical TSS. The MM patients had compromised humoral immunity because of depression of normal immunoglobulin (Ig) levels at the expense of the M protein. In addition, their T cells were absent due to high dose chemotherapy initiated for bone marrow transplantation. The MM cases lacked mucosal hyperemia, erythroderma and desquamation, but were otherwise indistinguishable from the TSS cases. All patients grew S. aureus and in each case, SAg genes were detected by PCR. In several cases, the plasma contained biological SAg activity resulting in Vβ specific proliferation of indicator T cellsin vitro. The same specific activity was observed with the supernatant fluids of S. aureus broth cultures from the respective bacterial isolates. This confirms the presence of bio-active toxins in the plasma but did not lead to full blown TSS when T cells were lacking. Thus, S. aureus sepsis/shock can be clinically distinguished from typical TSS, and we suggest that muco-cutaneous manifestations of TSS are the most telling signs of massive T-cell-dependent cytokine release.

KW - Immunodeficiency

KW - Multiple myeloma

KW - Staphylococcus aureus

KW - Superantigen

KW - Toxic shock syndrome

UR - http://www.scopus.com/inward/record.url?scp=0036243131&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036243131&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2249.2002.01805.x

DO - 10.1046/j.1365-2249.2002.01805.x

M3 - Article

C2 - 12033193

AN - SCOPUS:0036243131

VL - 128

SP - 131

EP - 139

JO - Clinical and Experimental Immunology

JF - Clinical and Experimental Immunology

SN - 0009-9104

IS - 1

ER -